Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Bellezza

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Expert Review of Respiratory Medicine|December 31, 2015
Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applicationsBiagio Ricciuti, Giulia Costanza Leonardi, Giulio Metro, et al.
Human Vaccines & Immunotherapeutics|May 18, 2021
Immune checkpoint inhibitors for unresectable malignant pleural mesotheliomaGiulio Metro, Diego Signorelli, Elio G Pizzutilo, et al.
Lung|March 2, 2025
Toll-Like Receptor 4 and 8 are Overexpressed in Lung Biopsies of Human Non-small Cell Lung CarcinomaSilvia Ceccarelli, Viola Pasqua Marzolesi, Jacopo Vannucci, et al.
Journal of Chemotherapy (Florence, Italy)|December 20, 2022
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two casesGiulio Metro, Sara Baglivo, Niccolò Metelli, et al.
Folia Morphologica|December 5, 2003
The correlation of protein peroxidation with morphological changes in experimental oestradiol-induced carcinogenesisJarosław Kobiela, Jolanta Kubasik-Juraniec, Tomasz Stefaniak, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2003
The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancerVanesa Gregorc, Samir Darwish, Vienna Ludovini, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancerVanesa Gregorc, Vienna Ludovini, Lorenza Pistola, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
OsimertinibUmberto Malapelle, Biagio Ricciuti, Sara Baglivo, et al.
Virchows Archiv : an International Journal of Pathology|September 10, 2013
Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC)Guido Bellezza, Rachele Del Sordo, Renato Colella, et al.
Interactive Cardiovascular and Thoracic Surgery|November 7, 2017
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinomaGuido Bellezza, Jacopo Vannucci, Fortunato Bianconi, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Expert Review of Respiratory Medicine|December 31, 2015
Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applicationsBiagio Ricciuti, Giulia Costanza Leonardi, Giulio Metro, et al.
Human Vaccines & Immunotherapeutics|May 18, 2021
Immune checkpoint inhibitors for unresectable malignant pleural mesotheliomaGiulio Metro, Diego Signorelli, Elio G Pizzutilo, et al.
Lung|March 2, 2025
Toll-Like Receptor 4 and 8 are Overexpressed in Lung Biopsies of Human Non-small Cell Lung CarcinomaSilvia Ceccarelli, Viola Pasqua Marzolesi, Jacopo Vannucci, et al.
Journal of Chemotherapy (Florence, Italy)|December 20, 2022
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two casesGiulio Metro, Sara Baglivo, Niccolò Metelli, et al.
Folia Morphologica|December 5, 2003
The correlation of protein peroxidation with morphological changes in experimental oestradiol-induced carcinogenesisJarosław Kobiela, Jolanta Kubasik-Juraniec, Tomasz Stefaniak, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2003
The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancerVanesa Gregorc, Samir Darwish, Vienna Ludovini, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancerVanesa Gregorc, Vienna Ludovini, Lorenza Pistola, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
OsimertinibUmberto Malapelle, Biagio Ricciuti, Sara Baglivo, et al.
Virchows Archiv : an International Journal of Pathology|September 10, 2013
Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC)Guido Bellezza, Rachele Del Sordo, Renato Colella, et al.
Interactive Cardiovascular and Thoracic Surgery|November 7, 2017
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinomaGuido Bellezza, Jacopo Vannucci, Fortunato Bianconi, et al.
Pageof 11